Guidelines for clinical evaluation of anti‐cancer drugs

Clinical studies intended for regulatory approval must demonstrate the clinical benefits of the drug in a target population. Clinical development of a drug proceeds by stepwise clinical studies; after safety and pharmacokinetics are evaluated and the recommended dosage and administration are determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Hironobu, Kiyota, Naomi, Kimbara, Shiro, Ando, Yuichi, Shimokata, Tomoya, Ohtsu, Atsushi, Fuse, Nozomu, Kuboki, Yasutoshi, Shimizu, Toshio, Yamamoto, Noboru, Nishio, Kazuto, Kawakami, Yutaka, Nihira, Shin‐ichi, Sase, Kazuhiro, Nonaka, Takahiro, Takahashi, Hideaki, Komori, Yukiko, Kiyohara, Koshin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253284/
https://www.ncbi.nlm.nih.gov/pubmed/33990993
http://dx.doi.org/10.1111/cas.14967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253284/
https://www.ncbi.nlm.nih.gov/pubmed/33990993
http://dx.doi.org/10.1111/cas.14967

Ejemplares similares